Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).
Data de publicación
2014Título da revista
Journal Of Clinical Oncology
Tipo de contido
Publicación de congreso